Alterome Therapeutics, Inc
Edit

Alterome Therapeutics, Inc

http://www.alterome.com/
Last activity: 10.07.2026
Active
Categories: BioTechDrugLEDMessangerMovingScience
Alterome Therapeutics, Inc. is a precision oncology biotech developing alteration-specific therapeutics to address high value and validated oncogenic drivers. We are a team with expertise in multiple areas of science and operations, dedicated to co-elevating toward our vision to bring life-changing and life-saving therapies to cancer patients. We believe in our journey, in each other, and in our ability to collaboratively develop therapies that will help end cancers. Thus, we seek the best people for our company and provide the resources they need to grow, develop, and accomplish our collective goals. We are moving forward with humility & empathy, fearlessness & resilience, with a sense of inclusion & belonging, open communication and a deep trust. And…we manage to have a lot of fun along the way!
Followers
657
Mentions
7
Persons
8
Location: United States, California, San Diego
Employees: 11-50
Total raised: $232M
Founded date: 2021

Investors 3

Funding Rounds 2

DateSeriesAmountInvestors
08.04.2024Series B$132M-
02.11.2022-$100M-

Persons 8

DateFirst NameLast NameTitleLinkedInLocation
-SanjeevThohanSenior Vic...linkedin.c...-
-ElisabethGardinerSenior Vic...linkedin.c...-
-XuefengZhuVice Presi...linkedin.c...-
-Artemiza (...ZaragozaSenior Man...linkedin.c...-
-K. ScottMoorefieldCOO/CBOlinkedin.c...-
-JenniferDawsonSr Directo...linkedin.c...-
-NikkiAlvarezDirector, ...linkedin.c...-
-GregGoodmanSr Directo...linkedin.c...-

Mentions in press and media 7

DateTitleDescription
09.04.2024Alterome Therapeutics Secures $132M to Drive Precision Oncology PipelineAlterome Therapeutics, a San Diego-based biopharmaceutical company, has successfully completed a $132M Series B funding round. The funding, led by Goldman Sachs Alternatives, will propel the advancement of the company's pipeline programs in...
08.04.2024Alterome Therapeutics Raises $132M in Series B FinancingAlterome Therapeutics, a San Diego, CA-based biopharmaceutical company developing small molecule targeted therapies for the treatment of cancer, raised $132M in Series B funding. The round was led by Goldman Sachs Alternatives, with partici...
03.04.2024Alterome Therapeutics Raises $132 Million in Series B Financing-
03.04.2024Alterome Therapeutics completes $132M Series B funding round to support pipeline programs advancement into clinicals-
02.11.2022Alterome Therapeutics Extends Series A to Nearly $100 Million to Advance Alteration-Specific Cancer Therapies-
-Alterome Therapeutics“Transforming the lives of cancer patients, one alteration at a time. Our Mission is to discover precise therapies and inspire hope for individuals affected by cancer.”
-Alterome Therapeutics“Alterome Therapeutics – Transforming the lives of cancer patients, one alteration at a time”

Reviews 0

Sign up to leave a review

Sign up Log In